Evidence map›Paper›PMID 33441847›Full record

ArticleScientific reports2021

Prediction of lithium response using genomic data.

William Stone, Abraham Nunes, Kazufumi Akiyama, Nirmala Akula, Raffaella Ardau, Jean-Michel Aubry, Lena Backlund, Michael Bauer, Frank Bellivier, Pablo Cervantes and 43 more

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Moving toward precision and personalized treatment strategies in psychiatry.The international journal of neuropsychopharmacology · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Lithium rescues dendritic abnormalities in Ank3 deficiency models through the synergic effects of GSK3β and cyclic AMP signaling pathways.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  7. Candidate biomarkers in psychiatric disorders: state of the field.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Pharmacogenomics of Lithium Response in Bipolar Disorder.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors.

William StoneFaculty of Computer Science, Dalhousie University, Halifax, NS, Canada.
Abraham NunesFaculty of Computer Science, Dalhousie University, Halifax, NS, Canada.
Kazufumi AkiyamaDepartment of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Nirmala AkulaNational Institute of Mental Health, Bethesda, USA.
Raffaella ArdauUnit of Clinical Pharmacology, University Hospital of Cagliari, Cagliari, Italy.
Jean-Michel AubryDepartment of Psychiatry, University of Geneva, Geneva, Switzerland.
Lena BacklundDepartment of Clinical Neuroscience, the Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden.
Michael BauerDepartment of Psychiatry and Psychotherapy, Medical Faculty, Technische Universität Berlin, Dresden, Germany.
Frank BellivierUniversité Paris Diderot, Paris, France.
Pablo CervantesDepartment of Psychiatry, McGill University, Montreal, Canada.
Hsi-Chung ChenDepartment of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
Caterina ChillottiUnit of Clinical Pharmacology, University Hospital of Cagliari, Cagliari, Italy.
Cristiana CruceanuDepartment of Translational Research, Max Planck Institute of Psychiatry, Munich, Germany.
Alexandre DayerDepartment of Psychiatry, University of Geneva, Geneva, Switzerland.
Franziska DegenhardtInstitute of Human Genetics, School of Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany.
Maria Del ZompoUnit of Clinical Pharmacology, University Hospital of Cagliari, Cagliari, Italy.
Andreas J ForstnerInstitute of Human Genetics, School of Medicine, University Hospital Bonn, University of Bonn, Bonn, Germany.
Mark FryeDepartment of Psychiatry, Mayo Clinic, Rochester, USA.
Janice M FullertonSchool of Psychiatry, University of New South Wales, Sydney, Australia.
Maria Grigoroiu-SerbanescuBiometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.
Paul GrofMood Disorders Center Ottawa, Ottawa, Canada.
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, Tokyo, Japan.
Liping HouNational Institute of Mental Health, Bethesda, USA.
Esther JiménezHospital Clinic, University of Barcelona, Barcelona, Spain.
Tadafumi KatoLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Wako, Japan.
John KelsoeDepartment of Psychiatry, UCSD, San Diego, CA, USA.
Sarah Kittel-SchneiderDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Frankfurt, Frankfurt am Main, Germany.
Po-Hsiu KuoInstitute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Ichiro KusumiDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Catharina LavebrattDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Mirko ManchiaDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Lina MartinssonDepartment of Clinical Neuroscience, the Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden.
Manuel MattheisenDepartment of Psychiatry, University of Wurzburg, Würzburg, Germany.
Francis J McMahonNational Institute of Mental Health, Bethesda, USA.
Vincent MillischerDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Philip B MitchellSchool of Psychiatry, University of New South Wales, Sydney, Australia.
Markus M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Claire O'DonovanDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Norio OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Claudia PisanuDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Andreas ReifDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Frankfurt, Frankfurt am Main, Germany.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Guy RouleauMontreal Neurological Institute, McGill University, Montreal, Canada.
Janusz RybakowskiDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Martin SchallingDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Peter R SchofieldSchool of Psychiatry, University of New South Wales, Sydney, Australia.
Thomas G SchulzeInstitute of Psychiatric Phenomics and Genomics, University of Munich, Munich, Germany.
Giovanni SeverinoDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Alessio SquassinaDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Julia VeehDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Frankfurt, Frankfurt am Main, Germany.
Eduard VietaHospital Clinic, University of Barcelona, Barcelona, Spain.
Thomas TrappenbergFaculty of Computer Science, Dalhousie University, Halifax, NS, Canada.
Martin AldaDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada. malda@dal.ca.

Funding

Identification of Genes Involved in Major Mood DisordersZIAMH002843 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$24.5M
Genetic Determinants of Antidepressant Response in the STAR*D CohortZIAMH002844 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$11.1M
6 · The paper itself

Abstract

Predicting lithium response prior to treatment could both expedite therapy and avoid exposure to side effects. Since lithium responsiveness may be heritable, its predictability based on genomic data is of interest. We thus evaluate the degree to which lithium response can be predicted with a machine learning (ML) approach using genomic data. Using the largest existing genomic dataset in the lithium response literature (n = 2210 across 14 international sites; 29% responders), we evaluated the degree to which lithium response could be predicted based on 47,465 genotyped single nucleotide polymorphisms using a supervised ML approach. Under appropriate cross-validation procedures, lithium response could be predicted to above-chance levels in two constituent sites (Halifax, Cohen's kappa 0.15, 95% confidence interval, CI [0.07, 0.24]; and Würzburg, kappa 0.2 [0.1, 0.3]). Variants with shared importance in these models showed over-representation of postsynaptic membrane related genes. Lithium response was not predictable in the pooled dataset (kappa 0.02 [- 0.01, 0.04]), although non-trivial performance was achieved within a restricted dataset including only those patients followed prospectively (kappa 0.09 [0.04, 0.14]). Genomic classification of lithium response remains a promising but difficult task. Classification performance could potentially be improved by further harmonization of data collection procedures.

Indexed as

AdolescentAdultBipolar DisorderFemaleGenomicsHumansLithiumMachine LearningMaleModels, GeneticPolymorphism, Single NucleotidePrognosisTreatment OutcomeYoung AdultLithium

Identifiers

PMID33441847
PMCPMC7806976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.